These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. Inhaled antibiotics in the treatment of non-cystic fibrosis bronchiectasis: clinical and drug delivery perspectives. Sugianto TD; Chan HK Expert Opin Drug Deliv; 2016; 13(1):7-22. PubMed ID: 26289675 [TBL] [Abstract][Full Text] [Related]
52. Results of Tobramycin Inhalation Therapy in Patients with Noncystic Fibrosis Bronchiectasis with Tanriverdi E; Yildirim BZ; Gul S; Chousein EGU; Turan D; Çınarka H; Özgül MA; Cetinkaya E J Aerosol Med Pulm Drug Deliv; 2021 Sep; 34(5):274-279. PubMed ID: 33351705 [No Abstract] [Full Text] [Related]
53. Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low-Dose Erythromycin Study Trial. Burr LD; Rogers GB; Chen AC; Hamilton BR; Pool GF; Taylor SL; Venter D; Bowler SD; Biga S; McGuckin MA Ann Am Thorac Soc; 2016 Oct; 13(10):1697-1703. PubMed ID: 27464029 [TBL] [Abstract][Full Text] [Related]
54. Inhaled steroids for bronchiectasis. Kapur N; Bell S; Kolbe J; Chang AB Cochrane Database Syst Rev; 2009 Jan; (1):CD000996. PubMed ID: 19160186 [TBL] [Abstract][Full Text] [Related]
55. Novel Inhalable Ciprofloxacin Dry Powders for Bronchiectasis Therapy: Mannitol-Silk Fibroin Binary Microparticles with High-Payload and Improved Aerosolized Properties. Liu C; Lin L; Huang Z; Wu Q; Jiang J; Lv L; Yu X; Quan G; Li G; Wu C AAPS PharmSciTech; 2019 Jan; 20(2):85. PubMed ID: 30673901 [TBL] [Abstract][Full Text] [Related]